Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

April 28, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Phase III results for TS-110 in osteoarthritis

April 23, 1997

Caspase-1 involved in the regulation of multiple cytokines

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

New COX-2 inhibitor from Searle

April 15, 1997

Immunex's Enbrel demonstrates positive safety profile in RA patients

April 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...